FIELD: medicine.
SUBSTANCE: present invention relates to a process for obtaining a mesenchymal stromal cell. To implement this process, stromal Wharton's jelly or part thereof is first isolated from the umbilical cord. Next, enzymatic treatment of stromal Wharton's jelly or part thereof is carried out with collagenase enzyme in the presence of platelet lysate (PL), thereby releasing at least one cell from stromal Wharton's jelly or part thereof. After that, at least one cell is propagated in a growth medium containing PL.
EFFECT: improved yield of mesenchymal stem cells.
15 cl, 24 dwg, 7 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING OSTEOGENETIC POTENTIAL OF MESENCHYMAL STROMAL CELLS | 2016 |
|
RU2674336C2 |
| METHOD FOR OBTAINING BIOSAFE CULTURE OF MESENCHYMAL STEM CELLS FROM GELATIN OF WHARTON OF HUMAN UMBILICAL CORD | 2016 |
|
RU2674344C2 |
| METHOD FOR OBTAINING MULTIPOTENT MESENCHEMIC STROMAL CELLS FROM UMBILICAL CORD OF NEWBORN | 2020 |
|
RU2744301C1 |
| METHOD OF OBTAINING THE CULTURE OF MESENCHYMAL HUMAN STEM CELLS FROM THE PERIVASCULAR SPACE OF THE VEIN OF UMBILICAL CORD | 2015 |
|
RU2620981C2 |
| METHOD OF OSTEOGENIC POTENTIAL ASSESSMENT FOR MESENCHYMAL STROMAL CELLS | 2007 |
|
RU2370771C2 |
| METHOD OF MODIFYING PROLIFERATIVE ACTIVITY AND DIFFERENTIAL POTENCY OF MULTIPOTENT MESENCHYMAL STROMAL CELLS | 2010 |
|
RU2418066C1 |
| BIOMEDICAL CELL PRODUCT BASED ON MAMMALIAN MESENCHYMAL STROMAL CELLS AND HEXAPEPTIDE | 2022 |
|
RU2781968C1 |
| MESENCHYMAL STROMAL CELLS FOR TREATING SEPSIS | 2015 |
|
RU2715866C2 |
| METHOD OF REMOVING CELLS FROM CULTURE SURFACE DURING SUBCULTURE OF MULTIPOTENT MESENCHYMAL STROMAL CELLS | 2008 |
|
RU2391400C1 |
| METHOD FOR OBTAINING OF BIOSAFE CULTURE OF MESENCHIMAL STEM CELLS FROM HUMAN CHORIONIC VILLAE | 2016 |
|
RU2645255C1 |
